Medtronic (NYSE:MDT) Earns Hold Rating from Needham & Company LLC

Needham & Company LLC reissued their hold rating on shares of Medtronic (NYSE:MDT – Free Report) in a report issued on Friday morning, Benzinga reports. Other analysts have also issued research reports about the company. Truist Financial boosted their target price on Medtronic from $87.00 to $90.00 and gave the company a hold rating in […]

Related Keywords

Canada ,Michael Marinaro ,Medtronic Company Profile ,Medtronic ,Equity Investment Corp ,Royal Bank ,Needham Company ,Loudon Investment Management ,Wealth Management ,Tower Research Capital ,International Assets Investment Management ,Free Report ,Get Free Report ,Investment Corp ,Investment Management ,Assets Investment Management ,Research Capital ,Cardiovascular Portfolio ,Medtronic Daily ,